Drugs / CF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04247984 Comparator | May 2018 → Apr 2021 | colorectal cancer | Chinese Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04247984 ↗ |
| Route | Intravenous | “300 mg/m2 intravenously administered on day 1 of a 2-week cycle.” NCT04247984 ↗ |